Literature DB >> 19428438

Interlaboratory comparison study of serum total testosterone [corrected] measurements performed by mass spectrometry methods.

Hubert W Vesper1, Shalender Bhasin, Christina Wang, Susan S Tai, Larry A Dodge, Ravinder J Singh, Judie Nelson, Susan Ohorodnik, Nigel J Clarke, Wael A Salameh, C Richard Parker, Raj Razdan, Elizabeth A Monsell, Gary L Myers.   

Abstract

BACKGROUND: Though mass spectrometry (MS) assays are increasingly used for routine clinical measurements of serum total testosterone (TT), information about the variability of results is limited. This study assessed the variability of TT measurement results from routine MS assays.
METHODS: Twenty serum samples (12 females, 8 males) were analyzed on 2 days by seven high performance liquid chromatography (HPLC), and one gas chromatography (GC)-tandem mass spectrometry (HPLC-MS/MS, GC-MS/MS) assays. Two samples (male and female) were provided in five replicates to assess the within-run variability. Results were compared against those obtained at National Institute of Standards and Technology (NIST). The within- and between-laboratory variability was assessed for each sample. Comparisons to the NIST results were performed using bias plot and Deming regression analysis.
RESULTS: The overall coefficient of variation of the results obtained with MS assays was <15%CV at >1.53 nmol/L and <34%CV at 0.3 nmol/L. The between-assay variability was the major contributor to the overall variability. The assay precision was the highest (<3%CV) with assays using liquid-liquid extraction for sample preparation or GC-MS/MS. The mean percent difference to the reference assay was 11%. The slopes of Deming regression analysis of the MS assays were between 0.903 and 1.138 (correlation coefficient: >0.996). TT concentrations for one assay were above the measurement range.
CONCLUSIONS: The variability of TT measurement results among MS assays is substantially smaller than that reported for immunoassays. The type of sample preparation may affect assay precision. Standardizing assays can further reduce the variability of measurement results.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19428438     DOI: 10.1016/j.steroids.2009.01.004

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  28 in total

1.  Relation between sex hormone concentrations, peripheral arterial disease, and change in ankle-brachial index: findings from the Framingham Heart Study.

Authors:  Robin Haring; Thomas G Travison; Shalender Bhasin; Ramachandran S Vasan; Henri Wallaschofski; Maithili N Davda; Andrea Coviello; Joanne M Murabito
Journal:  J Clin Endocrinol Metab       Date:  2011-09-21       Impact factor: 5.958

Review 2.  Importance of hypogonadism and testosterone replacement therapy in current urologic practice: a review.

Authors:  Wayne J G Hellstrom; Darius Paduch; Craig F Donatucci
Journal:  Int Urol Nephrol       Date:  2010-12-09       Impact factor: 2.370

3.  Estimating testosterone concentrations in adolescent girls: Comparison of two direct immunoassays to liquid chromatography-tandem mass spectrometry.

Authors:  Christopher R McCartney; Christine M Burt Solorzano; James T Patrie; John C Marshall; Daniel J Haisenleder
Journal:  Steroids       Date:  2018-09-12       Impact factor: 2.668

4.  Persistent apparent pancreatic β-cell defects in premenarchal PCOS relatives.

Authors:  Laura C Torchen; Naomi R Fogel; Wendy J Brickman; Rodis Paparodis; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2014-07-16       Impact factor: 5.958

5.  Hypogonadism: Easy to define, hard to diagnose, and controversial to treat.

Authors:  Joshua Sterling; Aaron M Bernie; Ranjith Ramasamy
Journal:  Can Urol Assoc J       Date:  2015 Jan-Feb       Impact factor: 1.862

6.  Serum Total Testosterone Concentrations in the US Household Population from the NHANES 2011-2012 Study Population.

Authors:  Hubert W Vesper; Yuesong Wang; Meghan Vidal; Julianne Cook Botelho; Samuel P Caudill
Journal:  Clin Chem       Date:  2015-10-28       Impact factor: 8.327

7.  Effect of radiotherapy for rectal cancer on ovarian androgen production.

Authors:  J Segelman; C Buchli; A Svanström Röjvall; P Matthiessen; S Arver; M Bottai; M Ahlberg; R Jasuja; A Flöter-Rådestad; A Martling
Journal:  Br J Surg       Date:  2018-09-12       Impact factor: 6.939

8.  Revisiting hyper- and hypo-androgenism by tandem mass spectrometry.

Authors:  Flaminia Fanelli; Alessandra Gambineri; Marco Mezzullo; Valentina Vicennati; Carla Pelusi; Renato Pasquali; Uberto Pagotto
Journal:  Rev Endocr Metab Disord       Date:  2013-06       Impact factor: 6.514

Review 9.  Holistic management of DSD.

Authors:  Caroline E Brain; Sarah M Creighton; Imran Mushtaq; Polly A Carmichael; Angela Barnicoat; John W Honour; Victor Larcher; John C Achermann
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-04       Impact factor: 4.690

10.  Total testosterone quantitative measurement in serum by LC-MS/MS.

Authors:  Yuesong Wang; Gabrielle D Gay; Julianne Cook Botelho; Samuel P Caudill; Hubert W Vesper
Journal:  Clin Chim Acta       Date:  2014-06-21       Impact factor: 3.786

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.